IPP Bureau
Dr. Reddy's enters the trade generics business in India
By IPP Bureau - June 24, 2023
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
Eugia Pharma signs voluntary license with Medicines Patent Pool to develop generic version of Nilotinib Capsules
By IPP Bureau - June 24, 2023
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
GenWorks Health launched GenStore
By IPP Bureau - June 23, 2023
GenWorks has scaled up its e-commerce platform in terms of building traffic
Elekta Unity MR Linac revolutionizes cancer care in India
By IPP Bureau - June 23, 2023
Venus Remedies receives approval to market meropenm in Spain
By IPP Bureau - June 23, 2023
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Augnito to launch ambient technology for clinical documentation
By IPP Bureau - June 23, 2023
Augnito’s AI comprehends all English accents with 99% accuracy
LVPEI raises awareness on antimicrobial resistance among medical students
By IPP Bureau - June 23, 2023
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
Polyplastics announces commercial availability of DURACON POM PM Series for medical industry
By IPP Bureau - June 23, 2023
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
Lupin receives USFDA approval for Tiotropium Dry Powder Inhaler
By IPP Bureau - June 22, 2023
This product will be manufactured at Lupin's Pithampur facility in India
Mandaviya reviews preparedness to the ongoing heat wave in 7 affected states
By IPP Bureau - June 22, 2023
Effective disaster response and management is a collaborative work
Quantiphi join hands with Pharmarack and Snowflake to drive AI based innovation
By IPP Bureau - June 21, 2023
This partnership will revolutionize Pharmarack's digital infrastructure with Snowflake's single, integrated platform to facilitate advanced analytic
Verix acquires start-up.ai
By IPP Bureau - June 21, 2023
The start-up.ai team will be integrated into Verix, boosting its innovative Life Science AI capabilities
DGCI grants Emergency Use Authorisation to Gennova mRNA Covid booster vaccine
By IPP Bureau - June 21, 2023
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
